Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 12.88
-0.16 (-1.23%)
Feb 6, 2026, 5:35 PM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.8 billion as of February 6, 2026. Its market cap has increased by 40.63% in one year.
Market Cap
2.80B
Enterprise Value
2.76B
Revenue
1.09B
Ranking
n/a
PE Ratio
66.61
Stock Price
€12.88
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.80B, an increase of 18.10%. That is a compound annual growth rate of 0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 2.80B | 1.56% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.75B |
| Laboratorios Farmaceuticos Rovi | 3.76B |
| Faes Farma | 1.63B |
| Pharma Mar | 1.33B |
| Clínica Baviera | 807.01M |
| Oryzon Genomics | 250.36M |
| Laboratorio Reig Jofre | 224.64M |
| Atrys Health | 222.31M |